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Abstract 
 
As problems of antibiotic resistance increase, a continuing need for effective bioactive wound dressings is anticipated 
for the treatment of infected chronic wounds. Naturally derived antibacterial agents, such as Manuka honey, consist of 
a mixture of compounds, more than one of which can influence antimicrobial potency. The non-peroxide bacteriostatic 
properties of Manuka honey have been previously linked to the presence of methylglyoxal (MGO). The incorporation 
of MGO as a functional antibacterial additive during fibre production was explored as a potential route for 
manufacturing wound dressing components. Synthetic MGO and polyvinyl alcohol (PVA) were fabricated into webs 
of sub-micron fibres by means of electrostatic spinning of an aqueous spinning solution. Composite fabrics were also 
produced by direct deposition of the PVA-MGO fibres onto a preformed spunbonded nonwoven substrate. Attenuated 
Total Reflectance Fourier Transform Infrared (ATR-FTIR) and Proton Nuclear Magnetic Resonance (
1
H-NMR) 
spectroscopies confirmed the presence of MGO within the resulting fibre structure. The antibacterial activity of the 
fibres was studied using strains of Staphylococcus aureus and Escherichia coli. Strong antibacterial activity, as well as 
diffusion of MGO from the fibres was observed at a concentration of 1.55mg/cm².  
 
Introduction 
Chronic wounds such as pressure ulcers and leg ulcers, cause patients pain and delayed healing occurs as a result of 
infection and biofilm formation on the surface of the wound
1
. Bacteria biofilms can harbour a host of different 
bacterial species including aerobic and anaerobic microorganisms, some of which include Methicillin-resistant 
Staphylococcus aureus (MRSA), Escherichia coli (E. Coli), beta-haemolytic Streptococci and Enterobacter cloacae
2
. 
As these bacteria start to show resistance to antibiotics
3, 4
, the use of topical wound dressings, containing antimicrobial 
compounds are an important tool for the treatment of infected chronic wounds. Numerous antimicrobial compounds 
used in combination with dressings have been clinically evaluated. Of these, the use of silver in topical antibacterial 
wound dressings
5, 6
 is particularly well established although potential toxic effects, such as argyria
7
 and cytotoxicity, 
have been reported in wound healing
8, 9
. Naturally occurring antimicrobial agents include Manuka honey, which relies 
upon an osmotic effect produced by the high sugar content, the presence of an enzyme that produces hydrogen 
peroxide and non-peroxide compounds to provide antibacterial function
10
. Methylglyoxal (MGO)
11
, a ketoaldehyde 
(Figure 1), is a non-peroxide antimicrobial compound present in Manuka honey and is a metabolite found within the 
human body and many other living organisms
12
.   
 
Figure 1. Chemical structure of Methylglyoxal 
 
MGO exhibits strong activity against malignant cancer cells and can stimulate the immune response system to target 
tumour cells
13
. Antiviral
14
 and antimalarial properties have also been reported
15
, as well as its use in liquid form as an 
antibacterial agent for wounds
16
. The toxicity of MGO in the presence of bacteria is thought to be attributed to MGO’s 
ability to modify cell compounds, including free amino acids
17,
 
18
, proteins 
17, 19, 20
  and nucleic acids
21
. It has also been 
reported that MGO is able to modify DNA in leukaemia cells and prostate cancer cells by the induction of apoptosis
13, 
22
. Another study reported that MGO was able to activate lymphocytes and macrophages against tumour cells
23
. 
Lymphocytes and macrophages also play an important role in the wound healing process
24
. MGO presents potential 
complications for patients with diabetic foot ulcers due to the formation of irreversible advanced glycation end 
products (AGEs) which can change collagen pathophysiology resulting in the disruption of normal collagen matrix 
remodelling 
25
. Another study has reported that MGO may lead to vascular complications in patients with diabetes
26
.  
 
Many clinically utilised wound dressings containing antimicrobials are based on nonwoven substrates, which are 
porous three-dimensional fibre assemblies. These dressings provide a vehicle to deliver the antimicrobial agent, but 
this is in addition to providing many other major functions critical to wound healing such as wound exudate 
management. Fibre-forming hygroscopic materials and hydrogels are particularly important raw materials in wound 
dressing design.  
 
Polyvinyl alcohol (PVA) is a polyhydroxy polymer, which is known to have good fibre forming properties
27
. It is 
water-soluble, biocompatible and approved by the FDA for medical use in humans
28
. PVA is also valuable as a 
hydrogel forming polymer. Hydrogels have a distinct advantage in wound healing, since they are water absorbing gel 
substances of varying rigidity
29
 that are able to provide a well-defined moist wound environment that allows a wound 
to heal faster than in a dry state
30
. The moist environment promotes epithelial cell migration from the wound edges, 
encourages modification of pH and oxygen levels, maintains an electrical gradient and retains wound fluid on the 
wound surface
31
. PVA has been previously studied as a potential wound dressing material because of its hydrogel 
forming properties
32, 33
 and its ability to provide controlled release of antibiotics into rats
34
. A recent study discussed 
PVA based hydrogel fluids, which on contact with glucose present in wound exudate formed a gel that moulded to the 
shape of the wound
35
. Typically, in the manufacture of nonwoven dressings, the antimicrobial compound is 
impregnated in to the nonwoven such that the constituent fibre surfaces are topically coated or it is incorporated within 
the fibres.  
 
Electrostatic spinning of PVA fibres containing a limited range of antibacterial agents for wound healing has 
previously been reported
36, 37
 and could provide a potential route for manufacturing thin fibre web layers that can be 
incorporated in to composite dressings. Additionally, the high specific surface area and porosity of electrospun fibre 
webs have the potential to absorb large volumes of fluid exudate from the wound, inhibiting exogenous 
microorganisms from entering the wound and to aid in fluid drainage
38
. The production and analysis of PVA-synthetic 
MGO fibres has yet to be systematically studied. The purpose of this study was to determine the feasibility of 
manufacturing fibres and fabrics from mixtures of PVA and MGO and to produce antibacterial fibres for potential use 
as part of a composite wound dressing material.  
 
Experimental 
Materials and methods: 
Materials: 
Poly (vinyl alcohol) with a molecular weight of 31-50,000 and a 40 wt% methylglyoxal aqueous solution were 
purchased from Sigma Aldrich UK. Polypropylene spunbond fabric (SPB) with a weight of 0.5g/m² was purchased 
from Elmarco s.r. in the Czech Republic. 
 
Preparation of PVA and PVA/MGO spinning solutions: 
Two separate solutions were prepared in the absence or presence of MGO. Preliminary experimental work indicated 
that an 8% (w/v) PVA solution enabled stable electrospinning conditions. In the former case, 0.8 g of PVA was 
dissolved in 10 ml of distilled water (Solution 1). For the preparation of MGO-containing solutions, 10 ml of 40 wt% 
MGO solution was diluted with 30 ml of distilled water to achieve a concentration of 11.22% (prepared MGO 
solution). 0.8g of PVA was dissolved in 10 ml of the prepared MGO solution (Solution 2). Both solutions were 
agitated for 2 hr at 80°C by magnetic stirring and left to cool to room temperature. 
 
Characterisation of PVA and PVA/MGO spinning solutions 
Viscosity measurements were made using a Brookfield DV-E Viscometer. Readings were taken at 22⁰C using spindle 
S18 at 60 r min
-1
. The surface tension of the solutions was measured using a Kruss tensiometer K100. A sample vessel 
with a diameter of 66.5 mm and a platinum plate was used to take the measurements at 22⁰C.   
 
Preparation of PVA and PVA/MGO fibre webs: 
The electrospinning equipment consisted of a syringe pump (KD Scientific Model 200 Series), a Glassman high 
voltage power supply and a grounded square (10 x 10cm) of polypropylene spunbond (SPB) nonwoven fabric used as 
the collector, was placed over a square (10 x 10cm) piece of aluminium foil. This enabled fibre webs to be directly 
combined on to the surface of a pre-formed reinforcing nonwoven fabric, to produce a composite. A 10 mL syringe 
was fitted with a 21 gauge blunt needle and the polymer solution was loaded into the syringe which was set to a feed 
rate of 0.1 mL hr
-1
 for 5 hr with a needle tip to collector distance of 10 cm and a voltage of 10kV. The temperature and 
humidity of the chamber was 20
o
C + 2
o
C and 43% ± 2%, respectively.    
 
Characterisation of PVA/MGO fibres 
Fibre Morphology 
The as-spun fibres in each collected fibre web were inspected using a Field Emission Gun Scanning Electron 
Microscope (FEGSEM) (Carl Zeiss LEO 1530). The mean fibre diameter was determined based on evaluation of 
individual fibres in the SEM images; the total number of measurements for each sample was 50. 
 
Fourier-transform infra-red (FTIR) spectroscopy  
Infra-red spectra of the PVA powder, 40 wt% MGO solution and PVA/MGO fibres were obtained using an FT-IR 
Perkin Elmer Spectrum BX with diamond ATR attachment system. The PVA powder and 40 wt% MGO solution were 
analysed with the diamond ATR system. PVA/MGO fibres were cut into small pieces and ground with KBr powder 
(Sigma Aldrich Chemicals) to make sample disks. This was done to ensure any MGO encapsulated within the fibres 
was made available for detection. Measurements were taken in the range between 4000 – 400 cm-1 with a resolution of 
4 cm
-1
. 64 repeat scans were averaged for each spectrum of the PVA powder and 40 wt % MGO solution, respectively, 
and 16 repeat scans were averaged for each spectrum of the PVA/MGO fibre KBr disk.  
 
1
H-NMR Spectroscopy 
10 mg of PVA powder, 40 wt% MGO solution and PVA/MGO fibres, respectively, were dissolved in 1mL of 
deuterium oxide and analysed in a Bruker Advance spectrometer 500 MHz 
1
H NMR spectrometer. The 
1
H-NMR 
spectra were the average of 1024 repetitions.   
 
Antibacterial studies:  
The PVA fibre SPB fabric composites, PVA/MGO fibre SPB fabric composites and SPB (polypropylene spunbond 
nonwoven fabric) alone were tested for antibacterial activity according to a standard protocol, BS EN ISO 20645:2004 
– Textile fabrics, determination of antibacterial activity, agar diffusion plate test. Both gram-positive and gram-
negative strains of bacterium were used, which included Staphylococcus aureus and Escherichia.coli. Both of the 
strains were used in accordance with the requisite standards and are common pathogens found in infected wounds. 
After 24 hours incubation at 37ºC, the microbial zone of inhibition was measured using optical microscopy.  
 
Results and discussion 
Fibre morphology 
Figures 2a and 2b show the morphology of fibres in fibre webs with and without MGO, respectively. Both reveal 
evidence of bead formation in the as-spun fibres, but the frequency was reduced in the fibres produced from the PVA-
MGO solution (Figure 2b). Beads were formed during electrospinning due to the capillary breakup of the 
electrospinning jets as a result of surface tension, which is affected by the presence of electrical forces
39
. Viscosity, 
which is strongly influenced by the concentration of the solution, is also key parameter pertinent to the elimination of 
beads
40
. The viscosity of the MGO-containing spinning solution was almost twice as high as the solution containing 
only PVA (Table 1). The increased viscosity affected the fibre morphology as evident in Figure 2b, where there 
appeared to be fewer beads along the length of individual fibres. By altering the solution concentration it is possible to 
increase the viscosity and the surface tension, thus smoothing the fibre morphology and reducing the formation of 
beads
41
. By reducing the molecular weight of the PVA, there will be fewer chain entanglements within the solution 
and a higher amount of free solvent. The free solvent molecules will tend to accumulate and form spherical beads due 
to the surface tension of the solution. Previous studies have also shown that addition of salts can increase the net 
density charge of the solution and by the addition of ionic salts, the charge density can be controlled in order to 
decrease the amount of bead formation
42, 43
. Temperature and humidity also affect fibre formation because of their 
influence on the evaporation rate of the solvent, which changes the viscosity of the polymer solution
44, but in the 
present work these effects were minimised by maintaining constant temperature and humidity in the spinning 
chamber.  
 
 
Figure 2. SEM micrographs of as-spun PVA fibres, (a), mean fibre diameter = 118nm and PVA/MGO fibres, (b), 
mean fibre diameter = 166nm. 
 
 
Table 1. Properties of aqueous PVA spinning solutions.  
Solution 
Composition of 
solution 
Surface Tension 
(mN/m) 
Viscosity 
(cPs) 
1  8% (w/v) PVA  46.5 18.5 
2 
 8% PVA (w/v)  
in prepared MGO 
solution  
52.2 35.7 
 
 
 Fourier-transform infra-red (FTIR) spectroscopy  
To determine the presence of MGO within the as-spun fibres, FTIR analysis was conducted in order to identify the 
absorption bands of MGO within the PVA/MGO fibres, Figure 3. MGO is a ketoaldehyde with a characteristic 
vibrational absorption peak at 1720 cm
-1
, which is attributed to the C=O stretching vibration in the ketone carbonyl. A 
peak at 1379 cm
-1
 was also observed and can be assigned to CH3
 
bending in MGO
45
. These characteristic spectral 
vibrations confirm the presence of MGO within the fibres. The other vibrational peaks observed in the spectra can be 
assigned to the base PVA polymerwhere the broad band centred at 3282 cm
-1
 is due to hydrogen-bonded O-H 
stretching vibration and the peak at 2905 cm
-1
 is attributed to C-H stretching in the polymer backbone. The peak at 
1419 cm
-1 
is the result of in-plane O-H bending. The peak at 1089 cm
-1
 is indicative of C-O stretching
45
. 
a b 
  
 
Figure 3. ATR-FTIR spectrum of PVA/MGO fibres 
 
 
 
1
H-NMR Spectroscopy 
In order to further verify the presence of MGO within the PVA/MGO fibres, 
1
H-NMR spectra of fibres obtained from 
MGO-containing solutions were recorded. The 
1
H-NMR spectra seen in Figure 4 of PVA/MGO fibres showed two 
singlet resonances at 1.408 and 2.337 ppm which can be assigned to the methyl protons present in the methylglyoxal 
di-hydrate and monohydrate, respectively, following the reaction of MGO with water
46
. In addition  the resonance 
peak at 5.309 ppm is assigned to be the alkyl proton of methylgyoxal monohydrate, which is in agreement with 
previous studies
46
. The resonance peaks observed at 1.750 ppm  and 4.075 ppm can also be  assigned to the protons of 
CH2
47
 and the  CH proton of the PVA, respectively. These spectral assignments have further confirmed the presence of 
MGO within the fibres. Consequently, solvent evaporation during electrospinning has proved to have minimal impact 
on MGO loading of resulting PVA fibres. 
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Figure 4. 
1
H-NMR spectra of PVA/MGO fibres. (1), (2) and (3) indicate the chemical formulas of MGO, MGO mono-hydrate 
and MGO di-hydrate, respectively.   
 
 
Antibacterial Studies 
Figure 5 shows visual images of the effect of fabric samples on the growth of E. coli and S. aureus after 24 hours 
incubation. Table 2 indicates the zone of inhibition for all samples and the calculated percentage concentrations of 
MGO in the PVA fibres. In the agar diffusion plate tests zones of inhibition were clearly evident only in the 
PVA/MGO SPB composites after 24 hours incubation, with the PVA/SPB and SPB samples functioning as 
experimental controls. The contact zone underneath the samples was examined for bacterial growth using optical 
microscopy at 20X magnification. There was no evidence of bacterial growth below the PVA/MGO samples, while 
moderate growth was evident below the PVA SPB and SPB samples. Thus, in the absence of MGO, there was 
insufficient antibacterial functionality to restrict growth. These results confirm that the fibre webs containing MGO 
exhibit toxicity against both common gram positive and gram negative strains of bacterium, with zones of inhibition 
of 9.1 mm (E. coli) with a MGO concentration of 1.55 mg cm
-
² and 11.4 mm (S. aureus) with a MGO concentration of 
2.35 mg cm
-
².  
 
A previous study reported the bactericidal activity of MGO in liquid and gel formulations against Staphylococcal 
species, including S. aureus and methicillin-resistant S. epidermidis (MRSE)
16
. Concentrations between 1.25 mg mL
-1 
(0.14 mg cm
-
²) and 15 mg mL
-1 
(1.72 mg cm
-
²) were tested in a 9 mm well. The results showed that at the lower 
concentration of 0.14 mg cm
-
², a zone of inhibition of approximately 20 mm for S. aureus and 16 mm for MRSE was 
formed. At the higher concentration of 1.72 mg cm
-
² zones of approximately 40 mm were recorded for both strains.  
 
 
a    b 
 
c    d    
 
e    f    
 
Figure 5. Antibacterial activity of PVA fibres on a spunbond nonwoven substrate, (a) and (b)  PVA/MGO fibres on a spunbond 
substrate, (c) and (d) and base spunbond nonwoven substrate, (e) and (f).  
 
These results highlight the fact that when MGO is in liquid or gel form, with a concentration of approximately one 
tenth (0.14 mg cm
-
²) than that present in the PVA/MGO fibre webs (1.55 mg cm
-
²) a zone of inhibition twice the size 
S.aureus E.coli 
S.aureus E.coli 
E.coli S.aureus 
can be achieved. This difference is not surprising given that the MGO is initially encapsulated within the fibre and is 
not initially freely available as in the liquid phase. On contact with the agar, the PVA fibres formed a gel, which 
promoted the diffusion of MGO from the fibres in to the surrounding bacterial strain, preventing bacterial growth. The 
kinetics of MGO release from the PVA fibres is the subject of further study and is likely to be affected by subsequent 
crosslinking. It is possible that some of the MGO may be retained in the PVA fibres after 24 hours depending on the 
molecular architecture of the hydrogel network.  
 
Table 2. Zone of inhibition for PVA fibres on a spunbond nonwoven substrate, PVA/MGO fibre on a spunbond 
nonwoven substrate and base spunbond nonwoven substrate against S. aureus and E. coli. 
 
 
 
 
 
 
 
 
 
 
Conclusions 
PVA/MGO fibres were successfully prepared by the electrospinning technique and were directly deposited as a thin 
fibre web layer onto a preformed PP nonwoven substrate. Although the fibre morphology can be further optimised to 
reduce bead content, it was demonstrated that it is feasible to manufacture a mechanically robust composite structure 
comprising an antibacterial layer of hydrogel-forming polymer and MGO. The presence of MGO within the fibres was 
confirmed using both FTIR and NMR analyses. The antibacterial study revealed that MGO incorporated within PVA 
fibres, supported on a PP spunbond fabric, produces zones of inhibition for both gram positive and gram negative 
strains of bacterium, based on MGO concentrations in the fibre web of 2.35 mg cm
-
² for S. aureus and 1.55 mg cm
-
² 
for E. coli. 
 
 
 
Sample ID Sample Bacteria Strain Zone of 
Inhibition (mm) 
 
Concentration of 
MGO 
(mg cm
-
²) 
a 
b 
c 
d 
e 
f 
PVA SPB 
PVA SPB 
PVA/MGO SPB 
PVA/MGO SPB 
SPB 
SPB 
S. aureus 
E. coli 
S. aureus 
E. coli 
S. aureus 
E. coli 
0 
0 
11.4 
9.1 
0 
0 
n/a 
n/a 
2.35 
1.55 
n/a 
n/a 
Acknowledgements  
The authors would like to thank Robert Davies for 
1
H-NMR spectra acquisition, Peter Parnell for assistance with the 
antimicrobial studies.  
 
Funding 
The financial support of the Clothworkers’ Foundation and the Clothworkers’ Centre for Textile Materials Innovation 
in Healthcare is gratefully acknowledged.  
 
References  
1. Percival. SL, Hill KE, Williams DW, Hooper. SJ, Thomas. DW and  Costerton. JW. A review of the scientific 
evidence for biofilms in wounds. Wound Repair Regen. 2012; 20: 647-57. 
 
2. Bowler. PG, Duerden. BI and Armstrong. DG. Wound microbiology and associated approaches to wound 
management. Clin Microbiol Rev. 2001; 14: 244-69. 
 
3. Tenover FC. Mechanisms of Antimicrobial Resistance in Bacteria. Am. J. Infect. Control. 2006; 34: S3-S10 
    
4. Howell-Jones. RS, Wilson. MJ, Hill. KE, Howard. AJ, Price. PE and Thomas. DW. A review of the 
microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother. 2005; 55: 143-9. 
 
5. Warriner. R and Burrell. R. Infection and the chronic wound: a focus on silver. Adv. Skin Wound Care. 2005; 
18 Suppl 1: 2-12. 
 
6. Bowler. P, Jones. S, Towers. V, Booth. R, Parsons. D and Walker. M. Dressing conformability and silver-
containing wound dressings. Wounds UK. 2010; 6: 14-20. 
 
7. Lansdown. ABG. Chapter 8: The toxicology of silver. Silver in healthcare: Its antimicrobial efficacy and 
safety in use. Cambridge: Royal Society of Chemistry, 2010, p. 164 -70. 
 
8. Poon. VKM and Burd. A. In vitro cytotoxity of silver: implication for clinical wound care. Burns. 2004; 30: 
140-7. 
 
9. Burd. A, Kwok. CH, Hung. SC, Chan. HS, Gu. HL, Wai. KL and Huang. L. A comparative study of the 
cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen. 
2007; 15: 94-104. 
 
10. Molan PC. Honey as a topical antibacterial agent for treatment of infected wounds. World Wide Wounds. New 
Zealand; 2001. 
 
11. Mavric. E, Wittmann. S, Barth. G and Henle. T. Identification and quantification of methylglyoxal as the 
dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Molecular 
Nutrition and Food Research. 2008; 52: 483-9. 
 
12. Talukdar. D, Chaudhuri. BS, Ray. M and Ray. S. Critical evaluation of toxic versus beneficial effects of 
methylglyoxal. Biochemistry (Moscow). 2009; 74: 1059-69. 
 
13. Antognelli.C, Mezzasoma. L, Fettucciari. K, Talesa.VN. A novel mechanism of methylglyoxal cytotoxicity in 
prostate cancer cells. Int J Biochem Cell Biol. 2013; 45: 836-44. 
 
14. Burris. TD, Wright JB, Moffett. RB, Heinzelman. RV, Strube. RE, Aspergren. BD, Lincoln. EH and White. 
JL. Antiviral compounds. I. Aliphatic glyoxals, α-hydroxyaldehydes, and related compounds. J Am Chem Soc. 1957; 
79: 1682-7. 
 
15. Pavlovic-Djuranovic. S, Kun. JFJ, Schultz. JE, Beitz. E. Dihydroxyacetone and methylglyoxal as permeants of 
the Plasmodium aquaglyceroporin inhibit parasite proliferation. Biochim Biophys Acta, Biomembr. 2006; 1758: 1012-
7. 
 
16. Fidaleo M, Zuorro A and Lavecchia R. Methylglyoxal: A New Weapon against Staphylococcal Wound 
Infections? Chem. Lett. 2010; 39: 322-3. 
 
17. Lo. TWC, Westwood. ME, McLellan. AC, Selwood. T and Thornalley. PJ. Binding and modification of 
proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N-acetylarginine, Nα-
acetylcysteine, and Nα-acetyllysine, and bovine serum albumin. J. Biol. Chem. 1994; 269: 32299-305. 
 
18. Takahashi K. Reactions of Phenylglyoxal and Related Reagents with Amino Acids. Journal of Biochemistry. 
1977; 81: 395-402. 
 
19. Westwood. ME,  McLellan. MC and Thornalley. PJ. Receptor-mediated Endocytic Uptakeo f Methylglyoxal-
modified Serum Albumin. J. Biol. Chem. 1994; 269: 32293-8. 
 
20. Takahashi K. Further Studies on Reaction of Phenylglyoxal and Related Reagents with Proteins. Journal of 
Biochemistry. 1977; 81: 403-14. 
 
21. Krymkiewicz N. Reactions of Methylglyoxal with Nucleic Acids. FEBS Letters. 1973; 29: 51-4. 
 
22. Kang. YB, Edwards. LG, Thornalley. PJ. Effect of methylglyoxal on human leukaemia 60 cell growth: 
Modification of DNA, G(1) growth arrest and induction of apoptosis. Leukemia Research. 1996; 20: 397-405. 
 
23. Bhattacharyya. N, Pal. A, Patra. S, Haldar. AK, Roy. S and Ray. M. Activation of macrophages and 
lymphocytes by methylglyoxal against tumor cells in the host. Int Immunopharmacol. 2008; 8: 1503-12. 
 
24. Hart J. Inflammation 1: Its Role in the Healing of Acute Wounds. Journal of Wound Care. 2002; 11. 
 
25. Sassi-Gaha. S, Loughlin. DT, Kappler. F, Schwartz. ML, Su. B, Tobia. AM and Artlett. CM Two dicarbonyl 
compounds, 3-deoxyglucosone and methylglyoxal, differentially modulate dermal fibroblasts. Matrix Biology. 2010; 
29: 127-34. 
 
26. Rabbani. N and Thornalley. PJ. Glyoxalase in diabetes, obesity and related disorders. Semin. Cell Dev. Biol. 
2011; 22: 309-17. 
 
27. Supaphol. P and Chuangchote. S. On the Electrospinning of Poly(vinyl alcohol) Nanofiber Mats: A Revisit. 
Journal of Applied Polymer Science. 2008; 108: 969–78  
 
28. Chong. SF, Smith. AA and Zelikin. AN. Microstructured, functional PVA hydrogels through bioconjugation 
with oligopeptides under physiological conditions.Small. 2013; 9: 942-50 
 
29. Schoukens G. Bioactive dressing to promote healing. In: Rajendran S, (ed.). Advanced Textiles for Wound 
Care. Boca Raton, USA: CRC Press and Woodhead Publishing Ltd, 2009, p. 114-52. 
 
30. Winter GD. Formation of the scab and the rate of epithelisation of superficial wounds in the skin of the young 
domestic pig. Nature. 1962; 4: 366-7. 
 
31. Schultz. GS, Sibbald. GR, Falanga. V, Ayello. EA, Dowsett. C, Harding. K, Romanelli. M, Stacey. MC, Teot. 
L and Vanscheidt. W. Wound Bed Preparation: a systematic approach to wound management. Wound Repair and 
Regeneration. 2003; 11: S1-S28. 
 
32. Singh. B and Pal L. Radiation crosslinking polymerization of sterculia polysaccharide-PVA-PVP for making 
hydrogel wound dressings. International Journal of Biological Macromolecules. 2011; 48: 501-10. 
 
33. Pal K, Banthia. AK, and Majumdar. DK. Preparation and characterization of polyvinyl alcohol-gelatin 
hydrogel membranes for biomedical applications. Aaps. Pharmscitech. 2007; 8. 
 
34. Moretto. A, Tesolin. L, Marsilio. F, Schiavon. M, Berna. M and Veronese. FM. Slow release of two 
antibiotics of veterinary interest from PVA hydrogels. Farmaco (Lausanne)  2003; 59: 1-5. 
 
35. Sakai. S, Tsumura. M, Inoue. M, Koga. Y, Fukanob. K and Taya. M. Polyvinyl alcohol-based hydrogel 
dressing gellable on-wound via a co-enzymatic reaction triggered by glucose in the wound exudate. Journal of 
Materials Chemistry B. 2013; 1: 5067-75. 
 
36. Liu X, Lin T, Fang J, Yao. G, Zhao. H, Dodson. M and Wang. X . In vivo wound healing and antibacterial 
performances of electrospun nanofibre membranes. Journal of Biomedical Materials Research Part A. 2010; 94A: 
499-508. 
 
37. Shalumon. KT, Anulekha. K, Nair. SV, Nair. SV, Chennazhi. KP and Jayakumar. R. Sodium 
alginate/poly(vinyl alcohol)/nano ZnO composite nanofibers for antibacterial wound dressings. International Journal 
of Biological Macromolecules. 2011; 49: 247-54. 
 
38. Myung-Seob. K, Dong-II. C, Hak-Yong. K, In-Shik. K and Narayan. B. Electrospun Nanofibrous 
Polyurethane Membrane as Wound Dressing. Journal of Biomedical Materials Research Part B: Applied 
Biomaterials. 2003. 
 
39. Fong. H, Chun. I, and Reneker. DH. Beaded nanofibers formed during electrospinning. Polymer. 1999; 40: 
4585–92. 
 
40. Tiwari. SK and Venkatraman. SS. Importance of viscosity parameters in electrospinning: Of monolithic and 
core–shell fibers. Materials Science and Engineering. 2012; 32:1037-42. 
 
41. Koski. A, Yim. K and Shivkumar. S. Effect of molecular weight on fibrous PVA produced by electrospinning 
Materials Letters 2004; 58: 493– 7. 
 
42. Kim SJ, Lee. CK and Kim SI. Effect of ionic salts on the processing of poly(2acrylamido-2-methyl-1-propane 
sulfortic acid) nanofibers. Journal of Applied Polymer Science. 2005; 96: 1388-93. 
 
43. Sun. Z, Deitzel. JM, Knopf. J, Chen. X and Gillespie. JW. The effect of solvent dielectric properties on the 
collection of oriented electrospun fibers. Journal of Applied Polymer Science. 2012; 125: 2585-94. 
 
44. De Vrieze. S, Van Camp. T, Nelvig. A, Hagström. B,  Westbroek. P and Clerck. KD. The effect of 
temperature and humidity of electrospinning. Journal of  Material Science. 2009; 44: 1357–62 
 
45. Pavia. DL, Lampman. GM, and Kriz. GS. Introduction to spectroscopy : a guide for students of organic 
chemistry Philadelphia: Saunders College, 1979. 
 
46. Petit. JM and Zhu. XX. 1H and 
13
C NMR Study on Local Dynamics of Poly(vinyl alcohol) in Aqueous 
Solutions. Macromolecules. 1996; 29: 2075-81. 
 
47. Donarski. JA, Roberts. DPT and Charlton. AJ. Quantitative NMR spectroscopy for the rapid measurement of 
methylglyoxal in Manuka honey. Analytical Methods. 2010; 2: 1479-83 
 
 
 
 
 
 
